• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T淋巴细胞基因调控的CCL5及其与肝细胞癌肝外转移的关系

T-Lymphocyte Gene-Regulated CCL5 and Its Association with Extrahepatic Metastasis in Hepatocellular Carcinoma.

作者信息

Dong Guoping, Fan Fangying, He Yao, Luo Yanchun, Yu Jie, Liang Ping

机构信息

Department of Interventional Ultrasound, Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100853, People's Republic of China.

Chinese PLA Medical School, Beijing, 100853, People's Republic of China.

出版信息

J Hepatocell Carcinoma. 2023 Aug 2;10:1267-1279. doi: 10.2147/JHC.S420836. eCollection 2023.

DOI:10.2147/JHC.S420836
PMID:37551333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10404438/
Abstract

BACKGROUND

Extrahepatic metastasis in hepatocellular carcinoma (HCC) greatly limits the prognostic survival of HCC patients. Levels of preoperative peripheral lymphocyte subsets and cytokines in the serum for predicting extrahepatic spread of hepatocellular carcinoma are still not common in clinical practice. The aim of this study is to investigate the value and mechanisms of peripheral lymphocyte subsets and cytokines in predicting extrahepatic spread of HCC.

METHODS

We used a retrospective design to analyze data pertaining to a total of 380 patients with HCC who were examined for peripheral T-lymphocyte subsets before receiving microwave ablation. We performed Cox regression analysis to screen out independent risk factors and used pathology specimens from the patients and public databases of liver cancer to investigate the correlation between cytokines and intra-tumor immune cells.

RESULTS

The CD4 group had better metastasis-free 1-year, 3-year, and 5-year survival rates compared to the CD4 group (80% vs 69%, 67% vs 51%, and 57% vs 39%, respectively; HR 1.7 (1.2, 2.3), P = 0.0019). Similarly, the CD8 group had better metastasis-free 1-year, 3-year, and 5-year survival rates compared to the CD8 group (65% vs 78%, 46% vs 64%, and 34% vs 54%, respectively; HR 0.6 (0.4, 0.8), P < 0.001). Patients with the CD4/CD8 phenotype had significantly worse metastasis-free survival times compared to other patients (HR 2.0 (1.5, 2.8), P < 0.001). Additionally, T lymphocyte-specific genes (CD4, CD8) were correlated with CCL5 expression, which was also positively correlated with the level of intra-tumoral infiltrating CD8 T cells and the prognosis of HCC patients.

CONCLUSION

Both CD4 and CD8 T lymphocyte subsets were independent risk factors for extrahepatic metastasis in HCC. Serum CCL5 levels could indicate the infiltration level of intra-tumoral CD8 T cells and the risk of extrahepatic metastasis in HCC patients, aiding in patient risk stratification for metastasis.

摘要

背景

肝细胞癌(HCC)的肝外转移极大地限制了HCC患者的预后生存。术前外周血淋巴细胞亚群水平和血清细胞因子用于预测肝细胞癌肝外转移在临床实践中仍不常见。本研究旨在探讨外周血淋巴细胞亚群和细胞因子在预测HCC肝外转移中的价值及机制。

方法

我们采用回顾性设计,分析了380例HCC患者在接受微波消融术前检测外周血T淋巴细胞亚群的数据。我们进行Cox回归分析以筛选出独立危险因素,并利用患者的病理标本和肝癌公共数据库研究细胞因子与肿瘤内免疫细胞之间的相关性。

结果

与CD4组相比,CD4组的1年、3年和5年无转移生存率更高(分别为80%对69%、67%对51%、57%对39%;HR 1.7(1.2,2.3),P = 0.0019)。同样,与CD8组相比,CD8组的1年、3年和5年无转移生存率更高(分别为65%对78%、46%对64%、34%对54%;HR 0.6(0.4,0.8),P < 0.001)。与其他患者相比,具有CD4/CD8表型的患者无转移生存时间明显更差(HR 2.0(1.5,2.8),P < 0.001)。此外,T淋巴细胞特异性基因(CD4、CD8)与CCL5表达相关,CCL5表达也与肿瘤内浸润性CD8 T细胞水平及HCC患者预后呈正相关。

结论

CD4和CD8 T淋巴细胞亚群均为HCC肝外转移的独立危险因素。血清CCL5水平可指示肿瘤内CD8 T细胞浸润水平及HCC患者肝外转移风险,有助于对转移患者进行风险分层。

相似文献

1
T-Lymphocyte Gene-Regulated CCL5 and Its Association with Extrahepatic Metastasis in Hepatocellular Carcinoma.T淋巴细胞基因调控的CCL5及其与肝细胞癌肝外转移的关系
J Hepatocell Carcinoma. 2023 Aug 2;10:1267-1279. doi: 10.2147/JHC.S420836. eCollection 2023.
2
Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.血清甲胎蛋白检测对预测接受微创治疗的肝细胞癌患者自体细胞因子诱导杀伤细胞相关临床结局的作用
Chin J Cancer. 2010 Jun;29(6):596-602. doi: 10.5732/cjc.009.10580.
3
Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.针对免疫检查点分子的抗体恢复了肝癌浸润 T 细胞的功能。
Gastroenterology. 2017 Oct;153(4):1107-1119.e10. doi: 10.1053/j.gastro.2017.06.017. Epub 2017 Jun 23.
4
Association of lymphocyte subsets with efficacy and prognosis of immune checkpoint inhibitor therapy in advanced non-small cell lung carcinoma: a retrospective study.淋巴细胞亚群与晚期非小细胞肺癌免疫检查点抑制剂治疗疗效和预后的相关性:一项回顾性研究。
BMC Pulm Med. 2022 Apr 28;22(1):166. doi: 10.1186/s12890-022-01951-x.
5
Peripheral blood lymphocyte subset levels differ in patients with hepatocellular carcinoma.肝细胞癌患者外周血淋巴细胞亚群水平存在差异。
Oncotarget. 2016 Nov 22;7(47):77558-77564. doi: 10.18632/oncotarget.13041.
6
Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma.多个基因的拷贝数异常被鉴定为肝癌患者肝外无转移生存的预后标志物。
Curr Med Sci. 2019 Oct;39(5):759-765. doi: 10.1007/s11596-019-2103-6. Epub 2019 Oct 14.
7
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].[一种肝切除术后肝细胞癌的新预后评分系统]
Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005.
8
The alterations in peripheral lymphocyte subsets predict the efficacy and prognosis of immune checkpoint inhibitors in hepatocellular carcinoma.外周血淋巴细胞亚群的改变可预测免疫检查点抑制剂在肝细胞癌中的疗效和预后。
J Cancer. 2023 Sep 11;14(15):2946-2955. doi: 10.7150/jca.88101. eCollection 2023.
9
Tumor-infiltrating FoxP3+ Tregs and CD8+ T cells affect the prognosis of hepatocellular carcinoma patients.肿瘤浸润的 FoxP3+ Tregs 和 CD8+ T 细胞影响肝癌患者的预后。
Digestion. 2012;86(4):329-37. doi: 10.1159/000342801. Epub 2012 Nov 28.
10
Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.六个细胞周期相关基因作为潜在的预后生物标志物,并与肝细胞癌中的免疫浸润相关。
J Cancer. 2023 Jan 1;14(1):9-23. doi: 10.7150/jca.76809. eCollection 2023.

本文引用的文献

1
Peripheral immune factors aiding clinical parameter for better early recurrence prediction of hepatocellular carcinoma after thermal ablation.外周免疫因子辅助临床参数,以更好地预测肝癌热消融治疗后早期复发。
Int J Hyperthermia. 2023;40(1):2172219. doi: 10.1080/02656736.2023.2172219.
2
Construction and validation of a prediction model of extrahepatic metastasis for hepatocellular carcinoma based on common clinically available data.基于常见临床可用数据构建并验证肝细胞癌肝外转移预测模型
Front Oncol. 2022 Nov 16;12:961194. doi: 10.3389/fonc.2022.961194. eCollection 2022.
3
Period-Dependent Survival Benefit of Percutaneous Microwave Ablation for Hepatocellular Carcinoma: A 12-Year Real-World, Multicentric Experience.
经皮微波消融治疗肝细胞癌的周期依赖性生存获益:一项12年的真实世界、多中心经验
Liver Cancer. 2022 Jan 28;11(4):341-353. doi: 10.1159/000522134. eCollection 2022 Jul.
4
Guidelines for Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus in China (2021 Edition).中国肝细胞癌合并门静脉癌栓诊断和治疗多学科专家共识(2021年版)
Liver Cancer. 2022 Mar 17;11(4):315-328. doi: 10.1159/000523997. eCollection 2022 Jul.
5
Eliminating METTL1-mediated accumulation of PMN-MDSCs prevents hepatocellular carcinoma recurrence after radiofrequency ablation.消除 METTL1 介导的 PMN-MDSCs 积聚可防止射频消融后肝癌复发。
Hepatology. 2023 Apr 1;77(4):1122-1138. doi: 10.1002/hep.32585. Epub 2022 Jul 8.
6
Cancer associated fibroblast-derived CCL5 promotes hepatocellular carcinoma metastasis through activating HIF1α/ZEB1 axis.癌症相关成纤维细胞衍生的 CCL5 通过激活 HIF1α/ZEB1 轴促进肝细胞癌转移。
Cell Death Dis. 2022 May 20;13(5):478. doi: 10.1038/s41419-022-04935-1.
7
NLRC3 High Expression Represents a Novel Predictor for Positive Overall Survival Correlated With CCL5 and CXCL9 in HCC Patients.NLRC3高表达代表了一种与肝癌患者CCL5和CXCL9相关的总生存期阳性的新型预测指标。
Front Oncol. 2022 Jan 25;12:815326. doi: 10.3389/fonc.2022.815326. eCollection 2022.
8
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.美国晚期黑色素瘤患者免疫疗法日间输注时间对总生存期的影响(MEMOIR):一项单中心纵向研究的倾向评分匹配分析。
Lancet Oncol. 2021 Dec;22(12):1777-1786. doi: 10.1016/S1470-2045(21)00546-5. Epub 2021 Nov 12.
9
Huaier granule prevents the recurrence of early-stage hepatocellular carcinoma after thermal ablation: A cohort study.槐耳颗粒预防热消融术后早期肝癌复发的队列研究。
J Ethnopharmacol. 2021 Dec 5;281:114539. doi: 10.1016/j.jep.2021.114539. Epub 2021 Aug 21.
10
Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.钆塞酸增强 MRI 特征对手术后增殖型肝细胞癌具有预后价值。
Radiology. 2021 Sep;300(3):572-582. doi: 10.1148/radiol.2021204352. Epub 2021 Jul 6.